Sterilized talc pleurodesis for malignant pleural effusions

a Phase II study for investigational new drug application in Japan

Saka, Hideo
Oki, Masahide
Kitagawa, Chiyoe
Kogure, Yoshihito
Kojima, Yuki
Saito, Akiko M
Ishida, Atsuko
Miyazawa, Teruomi
Takeda, Koji
Nakagawa, Kazuhiko
Sasada, Shinji
Negoro, Shunichi

Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Aichi
Clinical Research Center, National Hospital Organization, Nagoya Medical Center, Aichi
Department of Respiratory/Infectious Diseases, St. Marianna University School of Medicine Hospital, Kanagawa
Department of Medical Oncology, Osaka City General Hospital, Osaka
Department of Medical Oncology, Kindai University Hospital, Osaka
Department of Respiratory Medicine, Tokyo Saiseikai Central Hospital, Tokyo
Department of Medical Oncology, Hyogo Cancer Center, Hyogo, Japan

For reprints and all correspondence: Hideo Saka, Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Aichi, Japan. E-mail: [email protected]

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

Received August 28, 2017

Received in revised form January 29, 2018

Japanese Journal of Clinical Oncology 48(4):p 376-381, April 2018. | DOI: 10.1093/jjco/hyy020